Conventional transcutaneous electrical nerve stimulation shows no short-term safety signal in painful cervical dystonia: a pilot prospective study.
- 1Department of Neurology, University Hospital of Nancy, Nancy, France.
- 2Department of Clinical Epidemiology, INSERM, University of Lorraine and University Hospital of Nancy, Nancy, France.
- 3NGERE, INSERM, University of Lorraine, Nancy, France.
Abstract
Background and purpose
Cervical dystonia (CD) is frequently associated with chronic cervical pain refractory to botulinum neurotoxin (BoNT) therapy. Transcutaneous electrical nerve stimulation (TENS), a non-invasive neuromodulation technique with established analgesic properties, has not been formally evaluated in CD. This pilot study assessed the safety and tolerability of conventional TENS in painful CD, with exploratory evaluation of pain outcomes.Methods
This prospective, observational, single-arm study (NCT04949594) included patients with painful CD treated or not with BoNT. The primary outcome was the mean change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score between peak BoNT efficacy time points before (T1) and after TENS introduction (T2), assessed against an exploratory -8-point safety threshold. Secondary outcomes included TWSTRS subscores and Pain Numeric Rating Scale (PNRS).Results
Fifteen patients completed the study. The mean T1-T2 TWSTRS total score change was +3.42 (95% CI - 0.86 to 7.69), remaining above the exploratory -8-point safety threshold, with no group-level signal of clinically meaningful worsening. At the individual level, only three patients (20%) showed a worsening, two of whom (13.3%) exceeded the -8-point threshold (-11.5 and -9.5 points). TWSTRS subscores and PNRS showed no statistically significant changes after correction for multiple comparisons. Adverse events were mild and transient, and 80% of patients reported satisfaction and continued TENS use at follow-up.Conclusion
Conventional TENS showed no short-term safety signal and was well tolerated in painful CD, supporting its feasibility as an adjunctive neuromodulation approach in this small, uncontrolled pilot cohort, pending confirmation in randomized sham-controlled trials.
Related
- Transcutaneous electrical acupoint stimulation versus sham stimulation and dexamethasone versus amisulpride for preventing postoperative nausea and vomiting after laparoscopic gynecologic surgery: protocol for a randomized 2 × 2 factorial trial
- The efficacy of transcutaneous electrical nerve stimulation as an adjunctive therapy for perioperative pain management after total knee arthroplasty: an umbrella review.
- Combined transcutaneous electrical nerve stimulation and low-level laser photobiomodulation for postoperative pain after cesarean section: A randomized controlled trial
- Distinguishing clinical efficacy from vagal target engagement in perioperative transcutaneous auricular vagus nerve stimulation.
- Transcutaneous auricular vagus nerve stimulation demonstrates effects on pupil responses in Parkinson's disease
BibTeX
@article{becker2026conventional,
title = {{Conventional transcutaneous electrical nerve stimulation shows no short-term safety signal in painful cervical dystonia: a pilot prospective study.}},
author = {Jason Becker and Jonathan Epstein and Solène Frismand and Salomé Puisieux},
journal = {Frontiers in neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1909821},
url = {https://europepmc.org/article/MED/42908845},
note = {CC BY},
}
RIS
TY - JOUR
TI - Conventional transcutaneous electrical nerve stimulation shows no short-term safety signal in painful cervical dystonia: a pilot prospective study.
AU - Jason Becker
AU - Jonathan Epstein
AU - Solène Frismand
AU - Salomé Puisieux
PY - 2026
DA - 2026/10/07
JO - Frontiers in neurology
DO - 10.3389/fneur.2026.1909821
UR - https://europepmc.org/article/MED/42908845
AB - Background and purpose Cervical dystonia (CD) is frequently associated with chronic cervical pain refractory to botulinum neurotoxin (BoNT) therapy. Transcutaneous electrical nerve stimulation (TENS), a non-invasive neuromodulation technique with established analgesic properties, has not been formally evaluated in CD. This pilot study assessed the safety and tolerability of conventional TENS in painful CD, with exploratory evaluation of pain outcomes.Methods This prospective, observational, single-arm study (NCT04949594) included patients with painful CD treated or not with BoNT. The primary outcome was the mean change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score between peak BoNT efficacy time points before (T1) and after TENS introduction (T2), assessed against an exploratory -8-point safety threshold. Secondary outcomes included TWSTRS subscores and Pain Numeric Rating Scale (PNRS).Results Fifteen patients completed the study. The mean T1-T2 TWSTRS total score change was +3.42 (95% CI - 0.86 to 7.69), remaining above the exploratory -8-point safety threshold, with no group-level signal of clinically meaningful worsening. At the individual level, only three patients (20%) showed a worsening, two of whom (13.3%) exceeded the -8-point threshold (-11.5 and -9.5 points). TWSTRS subscores and PNRS showed no statistically significant changes after correction for multiple comparisons. Adverse events were mild and transient, and 80% of patients reported satisfaction and continued TENS use at follow-up.Conclusion Conventional TENS showed no short-term safety signal and was well tolerated in painful CD, supporting its feasibility as an adjunctive neuromodulation approach in this small, uncontrolled pilot cohort, pending confirmation in randomized sham-controlled trials.
SN - 1664-2295
ER -